The measurement of anti-Dsg3 in the PV group was carried out in treatment-naïve patients, while in the PF-anti-Dsg3+ group, three (20%) of the 15 patients (with information on treatment) were not receiving treatment (PF5, PF6 and PF14). Here, DSG3 is linked to acquired polycythemia vera.